Abstract
Melioidosis is an infectious disease endemic to northern Australia and Southeast Asia. In response to clinical confusion regarding the appropriate dose of amoxicillin-clavulanate, we have developed guidelines for the appropriate dosing of this second-line agent. For eradication therapy for melioidosis, we recommend 20/5 mg/kg orally, three times daily.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Oral
-
Adult
-
Amoxicillin-Potassium Clavulanate Combination / administration & dosage*
-
Anti-Bacterial Agents / administration & dosage*
-
Child
-
Drug Administration Schedule
-
Female
-
Humans
-
Infusions, Intravenous
-
Melioidosis / drug therapy*
-
Practice Guidelines as Topic
-
Pregnancy
-
Pregnancy Complications, Infectious / drug therapy
Substances
-
Anti-Bacterial Agents
-
Amoxicillin-Potassium Clavulanate Combination